targeting calpain-2 for people living with amyotrophic lateral sclerosis (ALS). With the clinical hold lifted, Amylyx is now working to open U.S. sites for screening, enrollment, and dosing.

Antimicrobials, vaccinations, and anti-inflammatory drugs were associated with a reduced risk of dementia in a systematic review, while diabetes drugs, vitamins and supplements, and antipsychotics ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis in which you experience relapses of the disease with periods of remission occurring in between. Relapsing-remitting multiple ...

Multiple sclerosis (MS) in its end stages involves disabling and life threatening effects. Several home adaptations and palliative care are available and can improve survival, mobility ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...

A current search of the database CINAHL produced no articles when the search terms "multiple sclerosis," "nursing" and "aging" were used. To initiate more dialogue about the role of nurses in ...

The ALS Association will host its second ALS Nexus conference in August, with the goal of making the disease a livable one ...